title: Ursodeoxycholic acid intervention in patients with familial adenomatous polyposis: a pilot study.
authors.forename: Marloes
authors.initials: M
authors.lastname: Berkhout
authors.forename: Hennie M J
authors.initials: HM
authors.lastname: Roelofs
authors.forename: Pieter
authors.initials: P
authors.lastname: Friederich
authors.forename: Annie
authors.initials: A
authors.lastname: van Schaik
authors.forename: Marleen J E M
authors.initials: MJ
authors.lastname: Gosens
authors.forename: Brigitte
authors.initials: B
authors.lastname: Marian
authors.forename: Beatrice L
authors.initials: BL
authors.lastname: Pool-Zobel
authors.forename: J Han J M
authors.initials: JH
authors.lastname: van Krieken
authors.forename: Wilbert H M
authors.initials: WH
authors.lastname: Peters
authors.forename: Fokko M
authors.initials: FM
authors.lastname: Nagengast
mesh_terms: D011125:Adenomatous Polyposis Coli / Q000188:drug therapy*; D000328:Adult; D001646:Bile / Q000737:chemistry / Q000187:drug effects; D045744:Cell Line, Tumor; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D051546:Cyclooxygenase 2 / Q000378:metabolism; D004386:Duodenum / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D018675:Toxicity Tests; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
chemical_list: D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid; D051546:Cyclooxygenase 2